Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation

被引：0
|
作者：
Koch, K. [1 ]
Herhaus, P. [1 ]
Osswald, L. [1 ]
Braitsch, K. [1 ]
Bassermann, F. [1 ]
Verbeek, M. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V639
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] Risk Factors for CMV Reactivation and Disease Among Hematopoietic Stem Cell Transplant Recipients Defining the Target Population for Letermovir Prophylaxis
    Ngyuen, Thao
    Kaivers, Jennifer
    Adams, Ortwin
    Lubke, Nadine
    Schroeder, Thomas
    Rautenberg, Christina
    Baermann, Ben-Niklas
    Ulrych, Thomas
    Haas, Rainer
    Timm, Joerg
    Kondakci, Mustafa
    Kobbe, Guido
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 497 - 498
  • [42] Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
    Kampouri, Eleftheria
    Zamora, Danniel
    Kiem, Erika S.
    Liu, Winnie
    Ibrahimi, Sarah
    Blazevic, Rachel L.
    Lovas, Erika A.
    Kimball, Louise E.
    Huang, Meei-Li
    Jerome, Keith R.
    Oshima, Masumi Ueda
    Mielcarek, Marco
    Zerr, Danielle M.
    Boeckh, Michael J.
    Krantz, Elizabeth M.
    Hill, Joshua A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (11) : 1450.e1 - 1450.e7
  • [43] Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study
    Brusosa, Marc
    Ruiz, Sonia
    Monge, Ines
    Solano, Maria Teresa
    Rosinol, Laura
    Esteve, Jordi
    Carreras, Enric
    Marcos, M. Angeles
    Riu, Gisela
    Carcelero, Esther
    Martinez, Carmen
    Fernandez-Aviles, Francesc
    Rovira, Montserrat
    Suarez-Lledo, Maria
    Salas, Maria Queralt
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 609 - 621
  • [44] Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study
    Studer, Ursina
    Khanna, Nina
    Leuzinger, Karoline
    Hirsch, Hans H.
    Heim, Dominik
    Lengerke, Claudia
    Tsakiris, Dimitrios A.
    Halter, Joerg
    Gerull, Sabine
    Passweg, Jakob
    Medinger, Michael
    Gwerder, Malena
    ANTICANCER RESEARCH, 2020, 40 (10) : 5909 - 5917
  • [45] Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
    Gill, Jessica
    Stella, Davide
    Dogliotti, Irene
    Dellacasa, Chiara
    Giaccone, Luisa
    Busca, Alessandro
    HEMATO, 2023, 4 (02): : 158 - 169
  • [46] Risk factors for CMV retinitis after allogeneic blood stem cell transplantation
    Larsson, K
    Ljungman, P
    Dekker, A
    Rovira, M
    Einsele, H
    Maertens, J
    Arcese, W
    Békàssy, A
    De La Cámara, R
    Graphakos, S
    Rio, B
    Arvidsson, J
    Wulffraat, N
    Cordonnier, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S53 - S53
  • [47] CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [48] PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL
    Lin, C. T.
    Wu, S. J.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Lin, W. P.
    Tang, J. L.
    Tien, H. F.
    HAEMATOLOGICA, 2014, 99 : 423 - 423
  • [49] CYTOMEGALOVIRUS (CMV) REACTIVATION AND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
    Ramanathan, M.
    Cerny, J.
    Shanahan, L.
    Kroll, A.
    Nath, R.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S468
  • [50] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    BLOOD, 2004, 104 (11) : 352B - 352B
12345